Psychiatry & Neurology, Neuromuscular Medicine · Hershey, PA
NPI
1649634528
Since 2016
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
30 Hope Dr Ste 1300
Hershey, PA, 17033
Phone (717) 531-3838
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
610 services
Medicare patients, 2024
223
Average age 68
Drug cost, 2024
$5.3M
1,358 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Xiaowei W Su was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 136 times for 101 patients. In total Xiaowei W Su billed 610 services in 27 codes, and Medicare paid $34K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 136 | 101 | $11.53 | $1,569 |
| 99214 Office E&M - Established | Facility | 135 | 85 | $60.32 | $8,143 |
| 95886 Electrical Nerve Conductivity | Office | 65 | 35 | $47.37 | $3,079 |
| 99233 Hospital E&M - Subsequent | Facility | 29 | 11 | $87.51 | $2,538 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 26 | 25 | $11.23 | $292 |
| 99215 Office E&M - Established | Facility | 25 | 23 | $103.70 | $2,593 |
| 99214 Office E&M - Established | Office | 24 | 22 | $81.01 | $1,944 |
| 95886 Electrical Nerve Conductivity | Facility | 21 | 12 | $33.69 | $708 |
| 99213 Office E&M - Established | Facility | 15 | 15 | $46.69 | $700 |
| 99205 Office E&M - New | Facility | 15 | 15 | $127.70 | $1,915 |
| 95910 Electrical Nerve Conductivity | Office | 12 | 12 | $98.05 | $1,177 |
By year: 2022 $37K for 481 services; 2023 $32K for 463 services; 2024 $34K for 610 services.
Medicare prescription drug claims, 2024
In 2024, the drug Xiaowei W Su prescribed most often to Medicare patients was Duloxetine Hcl, with 101 prescriptions and refills. In total Xiaowei W Su wrote 1,358 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 101 | 187 | 27 | $1,317 |
| Riluzole Generic | 88 | 221 | 33 | $22K |
| Baclofen Generic | 83 | 159 | 25 | $2,709 |
| Glycopyrrolate Generic | 54 | 93 | 22 | $2,154 |
| Gabapentin Generic | 53 | 111 | 17 | $1,040 |
| Pyridostigmine Bromide Generic | 51 | 146 | 15 | $6,535 |
| Lorazepam Generic | 40 | 49 | 16 | $381 |
| Radicava Ors Edaravone | 40 | 40 | Under 11 | $556K |
| Mirtazapine Generic | 40 | 60 | 14 | $322 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 36 | 36 | Under 11 | $224K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 36 | 36 | Under 11 | $590K |
| Sodium Chloride 0.9 % Sodium Chloride | 36 | 37 | Under 11 | $234 |
| Sertraline Hcl Generic | 35 | 71 | 14 | $528 |
| Tizanidine Hcl Generic | 35 | 57 | Under 11 | $1,401 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 33 | 33 | Under 11 | $682K |
Brand drugs: 316 claims; generic drugs: 1,042 claims; opioid claims: 50.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Xiaowei W Su were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.